References:
1.
Khoschsorur G, Frueehwirth F, Zelzer
S.Isocratic High-Performance Liquid Chromatographic Method with UV detection
for simultaneous determination of voriconazole and itraconazole and its
hydroxyl metabolite in human serum. Antimicrobial agents and Chemotherapy,
2005; 49: 3569-3571.
2.
Conway SP, Etherington C, Peckham DG et
al. Pharmacokinetics and safety of Itraconazole in patients with cystic
fibrosis. Journal of Antimicrobial Chemotherapy,2004; 53: 841-847.
3.
European Pharmacopoeia. Itraconazole,
Strasbourg: France, 4thEd, 2005; 1852-1853.
4.
Hay R.J, Dupont B, Graybill J.R. Review
Infectious Disease, 1987; 9(Suppl. 1): S1-3
5.
Saag M.S, Dismukes W.E. Antimicrobial
Agents Chemotherapy, 1988.
6.
Mechanism of action available online at URL http://www.drugbank.ca/drugs/DB01167.
7.
De Beule K, Van Gestel J. Pharmacology of
Itraconazole, 2001; 61(S1): 27–37.
8.
Pharmaceutical applications are available
online at URLhttp://www.nlm.nih.gov.
9.
Shalin K. Parikh, Ankit D. Patel, Dr J. B.
Dave, Dr C. N. Patel and Dr D. J. Sen, “Development and validation of UV
Spectrophotometric method for estimation of itraconazole bulk drug and
pharmaceutical formulation” International Journal of Drug Development and
Research, 2011; 3(2): 324-328.Stefanie Redmann, Bruce G. Charles, “A rapid HPLC
method with fluorometric detection for the determination of plasma itraconazole
and hydroxy-itraconazole concentrations in cystic fibrosis children with
allergic bronchopulmonary aspergillosis” BiomedicalChromatography, 2006; 20(4):
343–348.
10.
Kramer M, Marshall S, Denning D et al.
Cyclosporine and Itraconazole Interaction in Heart and Lung Transplant
Recipients. Annals of Internal Medicine, 1990; 113: 327–329.
11.
D. Vijaya Bharathi, Kishore Kumar Hotha,
P.V.Vidya Sagar, Sanagapati Sirish Kumar, Pandu Ranga Reddy, A. Naidu, Ramesh
Mullangi, “Development and validation of a highly sensitive and robust LC-MS/MS
with electrospray ionization method for simultaneous quantitation of
itraconazole and hydroxyitraconazole in human plasma” Science Direct Journal,
2008; 868(1-2): 70-76.
12.
Ming Yao, Laishun Chen, Nuggehally R
Srinivas, “Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass
spectrometry” Journal of Chromatography B: Biomedical Sciences and
Applications, 2001; 752(1)5: March 2001;916.
13.
Srivatsan V, Dasgupta A, Kale P, Datla R,
Soni D, Patel M, Patel R, and Mavadhiya, C. Simultaneous determination of
itraconazole and hydroxyitraconazole in human plasma by high-performance liquid
chromatography, Journal of Chromatography, 2004; 1031: 307-313.
14.
Zimmermann T, Yeates R.A, Laufen H.
European Journal of Clinical Pharmacology, 1994; 46: 147.
15.
Constantinos Kousoulos, Georgia Tsatsou,
Constantinos Apostolou, Yannis Dotsikas and Yannis L. Loukas, “Development of a
high-throughput method for the determination of itraconazole and its hydroxy
metabolite in human plasma, employing automated liquid-liquid extraction based
on 96-well format plates and LC/MS/MS ” Analytical and Bioanalytical Chemistry,
2006; 384(1): 199-207.
16.
M. V. Kumudhavalli, “Isocratic RP-HPLC, UV
Method Development and Validation Of Itraconazole In Capsule Dosage Form”
International Journal of Pharmaceutical Research IJPSR, 2011; 2(12): 3269-3271.
17.
Al-Rawithi H, Sameer M, Hussein A, Rajaa
Al-Moshen, Ibrahim, Raines, Dale, et al. Determination of Itraconazole and
Hydroxy itraconazole in Plasma by High-Performance Liquid Chromatography with
Fluorescence Detection, Therapeutic Drug Monitoring, 2001; 23: 445-448.
18.
El-Enany N, El-Sherbilny D, Belal F.
Spectrofluorimetric Determination of Itraconazole in Dosage Forms and Spiked
Human Plasma. Journal of the Chinese Chemical Society, 2007; 54: 375-382.